Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Dermatology

Understanding Alopecia Universalis: Biology and Validation

At a Glance

Alopecia Universalis (AU) is an autoimmune condition causing complete hair loss on the scalp and entire body. The immune system mistakenly attacks hair follicles, forcing them into a dormant state. Because the condition is non-scarring, the follicles are not dead and can potentially regrow hair.

Finding out you have Alopecia Universalis (AU) can feel like a sudden and overwhelming transformation. Unlike the more common patchy hair loss, AU involves the complete loss of hair on the scalp and the entire body, including eyebrows, eyelashes, and even tiny hairs inside the nose [1][2]. It is completely normal to feel a profound sense of shock or grief. This is not “just hair”; it is a major change to your physical identity and the protective barriers your body uses every day [3][4].

Understanding the Alopecia Spectrum

Alopecia is not a single experience but a spectrum of autoimmune activity. While you may hear these terms used interchangeably, they describe specific levels of hair loss:

  • Alopecia Areata (AA): This is the most common form, typically appearing as round or oval patches of hair loss on the scalp [1].
  • Alopecia Totalis (AT): This refers to the total loss of all hair on the scalp [1].
  • Alopecia Universalis (AU): This is the most extensive form, representing the loss of all hair across the entire body [1][2].

The Biology of AU: Why It Happens

Alopecia Universalis is an autoimmune disorder, which means your immune system has mistakenly identified your hair follicles as a threat. Specifically, your body’s defense system experiences a “collapse of immune privilege” [5][6]. Normally, hair follicles are “invisible” to the immune system. In AU, that invisibility disappears, and the body sends in autoreactive T cells—specifically a type called CD8+ T cells—to attack the follicle [5][7].

This attack is fueled by a communication loop called the JAK-STAT pathway. Think of this pathway like a cellular telephone line that transmits “attack” signals. In AU, these signals are constantly “on” due to inflammatory proteins called Th1 cytokines (specifically IFN-gamma and IL-15) [5][8]. These proteins keep the T cells active and aggressive, preventing your hair from growing [5].

Dormant, Not Dead

One of the most important things to understand about AU is that it is a non-scarring form of hair loss [3][5]. This means your hair follicles are not dead, destroyed, or gone. Instead, they are in a state of immune-mediated arrest or dormancy [6][9]. They are still there, just “stuck” in a resting phase because of the constant inflammation [6][10]. Because the follicles remain viable, they retain the potential to grow hair again if the immune attack is quieted [11][12].

The Emotional Weight of the Diagnosis

The sudden and complete nature of AU creates a unique psychological burden. Because the loss is total, patients often face an unpredictable journey and a significant shift in how they navigate the world [3][13]. Validating this experience is a crucial part of care. While the biological cause is an overactive immune system, the impact is felt in every social interaction and mirror reflection. Finding support—whether through mental health professionals, patient communities, or lifestyle changes like physical activity—can be a vital part of managing the “invisible” side of this condition [4].

Common questions in this guide

What is the difference between alopecia areata and alopecia universalis?
Alopecia areata typically involves round or oval patches of hair loss on the scalp. Alopecia universalis is the most extensive form on the spectrum, resulting in the complete loss of all hair on the scalp and the entire body.
Are my hair follicles dead if I have alopecia universalis?
No, your hair follicles are not dead or destroyed. Alopecia universalis is a non-scarring condition where the follicles are stuck in a dormant resting state due to immune inflammation, meaning they retain the potential to grow hair again.
Why does the immune system attack hair follicles?
In alopecia universalis, hair follicles lose their normal 'immune privilege' or invisibility to the immune system. This allows autoreactive T cells to mistakenly identify the follicles as a threat and attack them using inflammatory signals.
How does total hair loss affect my body's physical protection?
Beyond a change in appearance, losing all body hair removes natural protective barriers. The loss of eyebrows, eyelashes, and nose hairs can affect physical comfort by making it harder for your body to keep sweat, dust, and debris out of your eyes and airways.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Where does my diagnosis fall on the Alopecia Areata severity scale (SALT score)?
  2. 2.Can you explain my 'interferon gene signature' and if it predicts how I might respond to certain treatments?
  3. 3.Given that my hair follicles are dormant, what are the most effective ways to 'reactivate' them?
  4. 4.Should I be screened for other autoimmune conditions associated with AU?
  5. 5.What is the long-term outlook for someone with my specific duration and pattern of hair loss?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity.

    Bain KA, McDonald E, Moffat F, et al.

    The British journal of dermatology 2020; (182(1)):130-137 doi:10.1111/bjd.18008.

    PMID: 30980732
  2. 2

    Is Intralesional Methotrexate an Effective Alternative to Intralesional Triamcinolone in Alopecia Areata? Findings From a Randomized Controlled Trial.

    Ghandi N, Rashidi A, Saberi F, et al.

    Journal of cosmetic dermatology 2025; (24(8)):e70367 doi:10.1111/jocd.70367.

    PMID: 40736006
  3. 3

    Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications.

    Jadeja SD, Tobin DJ

    Frontiers in immunology 2022; (13()):890027 doi:10.3389/fimmu.2022.890027.

    PMID: 35720384
  4. 4

    The relationship between physical activity levels and symptoms of depression, anxiety and stress in individuals with alopecia Areata.

    Rajoo Y, Wong J, Cooper G, et al.

    BMC psychology 2019; (7(1)):48 doi:10.1186/s40359-019-0324-x.

    PMID: 31337438
  5. 5

    Rebound effect associated with JAK inhibitor use in the treatment of alopecia areata.

    Gordon SC, Abudu M, Zancanaro P, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(4)):e156-e157 doi:10.1111/jdv.15383.

    PMID: 30520145
  6. 6

    Immunology of alopecia areata.

    Żeberkiewicz M, Rudnicka L, Malejczyk J

    Central-European journal of immunology 2020; (45(3)):325-333 doi:10.5114/ceji.2020.101264.

    PMID: 33437185
  7. 7

    Vitamin D and alopecia areata: possible roles in pathogenesis and potential implications for therapy.

    Lin X, Meng X, Song Z

    American journal of translational research 2019; (11(9)):5285-5300.

    PMID: 31632510
  8. 8

    A cross-sectional study of the histopathology and immunology of alopecia areata: Unearthing the role of the Janus kinase-signal transducer and activator of transcription pathway.

    Bansal A, Relhan V, Garg VK, Saran RK

    Indian journal of dermatology, venereology and leprology 2019; (85(5)):455-461 doi:10.4103/ijdvl.IJDVL_738_17.

    PMID: 31031313
  9. 9

    Alopecia areata: a review of disease pathogenesis.

    Rajabi F, Drake LA, Senna MM, Rezaei N

    The British journal of dermatology 2018; (179(5)):1033-1048 doi:10.1111/bjd.16808.

    PMID: 29791718
  10. 10

    Alopecias in humans: biology, pathomechanisms and emerging therapies.

    Willems A, Sinclair R

    Veterinary dermatology 2021; (32(6)):596-e159 doi:10.1111/vde.13014.

    PMID: 34431565
  11. 11

    Two Phase 3 Trials of Baricitinib for Alopecia Areata.

    King B, Ohyama M, Kwon O, et al.

    The New England journal of medicine 2022; (386(18)):1687-1699 doi:10.1056/NEJMoa2110343.

    PMID: 35334197
  12. 12

    Excellent response to tofacitinib treatment in a patient with alopecia universalis.

    Erduran F, Adışen E, Aksakal AB

    Acta dermatovenerologica Alpina, Pannonica, et Adriatica 2017; (26(2)):47-49 doi:10.15570/actaapa.2017.15.

    PMID: 28632888
  13. 13

    Long-Term Prognosis of Alopecia Totalis and Alopecia Universalis: A Longitudinal Study with More than 10 Years of Follow-Up: Better than Reported.

    Jang YH, Hong NS, Moon SY, et al.

    Dermatology (Basel, Switzerland) 2017; (233(2-3)):250-256 doi:10.1159/000477458.

    PMID: 28704810

This page explains the biology of Alopecia Universalis for educational purposes. Always consult your dermatologist or healthcare provider for an accurate diagnosis and to discuss potential treatment options.

Get notified when new evidence is published on Alopecia universalis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.